Clinical Trial Update: A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of IBI362 for weight loss in overweight and obese Chinese adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• IBI362

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Overweight/ Obesity | Phase 2 | Status: COMPLETED